Related references
Note: Only part of the references are listed.Increased serum levels of S100A1, ZAGAG, and adiponectin in cachectic patients with COPD
Amin Mokari-Yamchi et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Down-regulation of S100A1 protein in patients with metabolic syndrome and its association with zinc-2-glycoprotein
Elham Ebrahimi et al.
SCOTTISH MEDICAL JOURNAL (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
KARDIOLOGIA POLSKA (2016)
S100A1 transgenic treatment of acute heart failure causes proteomic changes in rats
Yichen Guo et al.
MOLECULAR MEDICINE REPORTS (2016)
Epidemiology and aetiology of heart failure
Boback Ziaeian et al.
NATURE REVIEWS CARDIOLOGY (2016)
Anorexia of Aging: Risk Factors, Consequences, and Potential Treatments
Francesco Landi et al.
NUTRIENTS (2016)
Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016
Stephan von Haehling et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Zinc-α2-Glycoprotein Exerts Antifibrotic Effects in Kidney and Heart
Inga Soerensen-Zender et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Contribution of Major Lifestyle Risk Factors for Incident Heart Failure in Older Adults The Cardiovascular Health Study
Liana C. Del Gobbo et al.
JACC-HEART FAILURE (2015)
S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4
David Rohde et al.
EMBO MOLECULAR MEDICINE (2014)
The annual global economic burden of heart failure
Christopher Cook et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Heart failure: preventing disease and death worldwide
Piotr Ponikowski et al.
ESC HEART FAILURE (2014)
S100A1: a Major Player in Cardiovascular Performance
S. Duarte-Costa et al.
PHYSIOLOGICAL RESEARCH (2014)
Ghrelin: Central and Peripheral Implications in Anorexia Nervosa
Mathieu Méquinion et al.
Frontiers in Endocrinology (2013)
Is zinc-α2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis?
Viviane O. Leal et al.
CLINICA CHIMICA ACTA (2012)
Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers
Stefano Tedeschi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Nutritional markers and prognosis in cardiac cachexia
Jose Paulo Araujo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
S100A1 Genetically Targeted Therapy Reverses Dysfunction of Human Failing Cardiomyocytes
Henriette Brinks et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Cardiac AAV9-S100A1 Gene Therapy Rescues Post-Ischemic Heart Failure in a Preclinical Large Animal Model
Sven T. Pleger et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
In vitro aging of 3T3-L1 mouse adipocytes leads to altered metabolism and response to inflammation
Elena Zoico et al.
BIOGERONTOLOGY (2010)
The adipokine zinc-α2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity
T. Mracek et al.
CLINICAL ENDOCRINOLOGY (2010)
Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction
Jean-Francois Desjardins et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Zinc-α2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue
F-Y Gong et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
Lower Zinc-α2-Glycoprotein Production by Adipose Tissue and Liver in Obese Patients Unrelated to Insulin Resistance
David M. Selva et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Cachexia: A new definition
William J. Evans et al.
CLINICAL NUTRITION (2008)
Zinc α2-glycoprotein:: A multidisciplinary protein
Md Imtaiyaz Hassan et al.
MOLECULAR CANCER RESEARCH (2008)
S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance
Patrick Most et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Ca2+-dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes
Melanie Boerries et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction
Patrick Most et al.
CIRCULATION (2006)
Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia
C Bing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
S100A1:: A regulator of myocardial contractility
P Most et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
S100A1, a new marker for acute myocardial ischemia
R Kiewitz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Reproducibility, power and validity of visual analogue scares in assessment of appetite sensations in single test meal studies
A Flint et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Share Paper
